跳至主要内容
临床试验/NCT01562041
NCT01562041终止2 期

Evaluation of Exercise Treadmill Test Indices in Patients With Cardiovascular Disease

Novartis Pharmaceuticals1 个研究点 分布在 1 个国家目标入组 14 人开始时间: 2012年3月9日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
终止
入组人数
14
试验地点
1
主要终点
Change From Baseline in Maximum ST Segment Change Adjusted for Heart Rate (ST-HR) Index

研究概览

简要总结

The study was designed to evaluate the use of ETT electrocardiogram (ECG) indices as biomarkers in the assessment of atherosclerotic coronary vascular disease (ASCVD).

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
40 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • History of stable coronary artery disease

排除标准

  • Inability or unwillingness to participate in multiple exercise treadmill tests and/or any other requirements of this study as assessed by the Investigator.
  • History of chronic atrial fibrillation.
  • Other protocol-defined inclusion/exclusion criteria may apply.

研究组 & 干预措施

Ranolazine 500 mg

Experimental

Participants received ranolazine 500 milligrams (mg), orally, twice daily (b.i.d.) up to 14 days.

干预措施: Ranolazine 500 mg (Drug)

结局指标

主要结局

Change From Baseline in Maximum ST Segment Change Adjusted for Heart Rate (ST-HR) Index

时间窗: Baseline up to Day 15

ST/HR index was measured as the average change in ST segment depression relative to heart rate change over the entire duration of exercise, monitored by ECG during the exercise treadmill tests. Change in maximum ST/HR index between the average of tests 1-3 (pre Ranexa® treatment) performed during baseline period and test 4 (post Ranexa® treatment) during treatment period was reported.

Change From Baseline in Maximum ST Segment Change Adjusted for Heart Rate (ST-HR) Slope

时间窗: Baseline up to Day 15

ST-HR slope is an index of exercise induced ischemia. Linear regression was used to determine the slope of the ST/HR relationship in a participant's ECG response monitored during the exercise treadmill test. The highest ST segment/heart rate slope from among all the ECG leads and the X-axis intercept of the associated line were used to generate the maximum slope. Change in maximum ST-HR slope between the average of tests 1-3 (pre Ranexa® treatment) performed during baseline period and test 4 (post Ranexa® treatment) during treatment period was reported.

Change From Baseline in X-Axis Intercept of ST-HR Slope

时间窗: Baseline up to Day 15

Linear regression was used to determine the slope of the ST/HR relationship in a participant's ECG response monitored during the exercise treadmill test. Change in X- axis intercept of ST-HR slope between the average of tests 1-3 (pre Ranexa® treatment) performed during baseline period and test 4 (post Ranexa® treatment) during treatment period was reported.

次要结局

  • Change From Baseline in Total Exercise Duration(Baseline up to Day 15)
  • Change From Baseline in Time to Onset of 1 mm ST Segment Depression (Time to Ischemia)(Baseline up to Day 15)
  • Change From Baseline in Time to Onset of Angina(Baseline up to Day 15)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Evaluation of Exercise Treadmill Test (ETT) Indices... | 临床试验